XBI
ETF
Biotechnology
NYSEARCA
SPDR S&P Biotech ETF
$157.37
+2.87 (+1.86%)
Fund Overview
by SPDR (State Street)
Equal-weighted biotech ETF. Gives small-cap clinical-stage biotech companies equal weight with large-cap pharma-like biotechs, creating a higher risk/reward profile. When biotech M&A heats up, XBI often outperforms.
AUM$6.5B
Expense Ratio0.35%
Holdings145
Dividend Yield0.1%
DistributionQuarterly
BenchmarkS&P Biotechnology Select Industry Index
InceptionJan 2006
ExchangeNYSEARCA
Price Data
Open$156.87
Prev Close$154.50
Day Range$154.96 — $157.85
52W Range$66.66 — $132.09
52-Week Range
$66.66
$132.09
From 52W High
19.1%
From 52W Low
+136.1%
Investment Calculator
See how much dividend income XBI could generate based on its current price of $157.37 and 0.1% yield. Adjust the amount to estimate your quarterly distributions.
$
Shares Purchased
Amount Invested$9,914.31
Annual Income$9.91
Monthly Income$0.83
Based on current dividend yield of 0.1%. Actual distributions may vary. Past dividends do not guarantee future payments.
Biotechnology ETF Comparison
Top Biotechnology Stocks
View all →
| Stock | Price | Change | Market Cap |
|---|---|---|---|
| ABBV | $246.04 | +0.89% | 430.95B |
| AMGN | $410.95 | +1.51% | 219.39B |
| GILD | $133.21 | +1.80% | 165.85B |
| VRTX | $496.07 | +2.49% | 124.51B |
| REGN | $784.36 | +1.59% | 79.53B |
| NTRA | $322.10 | +21.37% | 45.33B |
| RVMD | $205.15 | +3.71% | 43.85B |
| BIIB | $207.94 | +0.80% | 30.26B |
| ALNY | $219.20 | +1.43% | 28.41B |
| INSM | $131.10 | -1.09% | 27.86B |
XBI FAQ
What is XBI?
XBI is the SPDR S&P Biotech ETF, an exchange-traded fund managed by SPDR (State Street). It tracks the S&P Biotechnology Select Industry Index and holds 145 Biotechnology securities with an expense ratio of 0.35%.
What is the expense ratio of XBI?
XBI charges an annual expense ratio of 0.35%, which means you pay $35.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does XBI pay dividends?
Yes, XBI pays a 0.1% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $10.00 per year in dividend income.
Explore Biotechnology Stocks
View our full list of individual biotechnology stocks with prices, fundamentals, and analyst ratings.
Last updated: Aug 7, 2026 at 10:14 PM ET